Drug Profile
Metronidazole vaginal - BTG/CeNeS
Alternative Names: Metronidazole Hycore-VLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator BTG
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial vaginosis
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 27 Oct 2004 Discontinued - Clinical-Phase-Unknown for Bacterial vaginosis in USA (Vaginal)
- 27 Oct 2004 Discontinued - Phase-II for Bacterial vaginosis in United Kingdom (Vaginal)